0001567619-21-015952.txt : 20210817
0001567619-21-015952.hdr.sgml : 20210817
20210817065017
ACCESSION NUMBER: 0001567619-21-015952
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210812
FILED AS OF DATE: 20210817
DATE AS OF CHANGE: 20210817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Helsel Dave
CENTRAL INDEX KEY: 0001543753
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50761
FILM NUMBER: 211180844
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANGIODYNAMICS INC
CENTRAL INDEX KEY: 0001275187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 113146460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
BUSINESS PHONE: 5187981215
MAIL ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
4
1
doc1.xml
FORM 4
X0306
4
2021-08-12
0
0001275187
ANGIODYNAMICS INC
ANGO
0001543753
Helsel Dave
14 PLAZA DRIVE
LATHAM
NY
12110
0
1
0
0
SVP Global Operations and R&D
Common Stock
2021-08-12
4
M
0
2685
0
A
24507
D
Common Stock
2021-08-12
4
F
0
788
27.29
D
23719
D
Performance Right
2021-08-12
4
M
0
6945
0
D
Common Stock
6945
0
D
Performance Right
Common Stock
8116
8116
D
This acquisition of 2,685 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019.
The exempt disposition of 788 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019.
On October 16, 2019, the reporting person received a target grant of 6,945 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited.
These securities were previously reported on the Form 4 filed by the reporting person on July 23, 2021. Due to a clerical error, the vesting terms were incorrectly stated in footnote 5 thereof. The correct number of target shares of Common Stock that may be earned includes a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate).
/s/ Richard C. Rosenzweig, Attorney in Fact
2021-08-16